European Journal of Cardiovascular Medicine

Background: In view of recent guidelines in the management of obstructive airway disease advocate the early use of oral and inhaled steroids which intern responsible for many side effects extending up to many organ systems including eye also by developing rise of intra ocular pressure ranging from 15 to 30 mm of Hg after daily topical steroid use for 4-5 weeks. So basing on this, the present study was planned to estimate the risk of ocular hypertension among the patient under inhaled corticosteroids. Research Question: What is the incidence of ocular hypertension among the patients under inhaled corticosteroids? The setting of the study was at department of ophthalmology, “Government Medical College”, Machilipatnam, Andhra Pradesh. A twelve months observational follow-up study was conducted during the period from July 2022 to June 2023 on 100 patients of COPD under inhaled corticosteroids attending the hospital by targeting their socio-demographic profiles and periodical measurement of their IOP etc. Results: All the study subjects were heterosexuals among which 56% males & 44% were females and majority of the study group (54%) belongs to between 50-55 years of age  with the mean age 55.2 yrs [M ± 2SE = 55.2 ± 1.16]. About 7% of the study group developed ocular hypertension at the end of 6 months with the rise of female contribution 63% when compared to males 37%. And also it was observed that there was significant rise of ocular hypertension proportionate to age, dosage and duration in this study with the P<0.001.